title: iZumi's plans to capitalize on iPS cells.
authors: Nature Reports Stem Cells, San Francisco, USA.
authors: Monya
authors: M
authors: Baker
mesh_terms: D001709:Biotechnology / Q000191:economics*; D049674:History, 21st Century; D006801:Humans; D007221:Industry; D018973:Intellectual Property; D039904:Pluripotent Stem Cells